Common diabetes drug metformin may slow age-related vision loss.
An observational study of about 2,000 people with diabetes found that those over 55 taking metformin were 37% less likely to develop intermediate age-related macular degeneration over five years; researchers say the result shows an association but does not prove causation and call for clinical trials.
